An Evaluation of 3-Rhamnosylquercetin, a Glycosylated Form of Quercetin, against the Myotoxic and Edematogenic Effects of sPLA<sub>2</sub> from <i>Crotalus durissus terrificus</i>

<table>Purification and chemical modification of secretory phospholipase A<sub>2</sub> (sPLA<sub>2</sub>). A fractionation of the whole venom was performed by reverse-phase HPLC (C5 column, 0.10 cm × 25 cm) using a nonlinear concentration gradient of buffer to obtain a high-purity protein. (a) shows a comparative profile of native sPLA<sub>2</sub>, sPLA<sub>2</sub> : Q, and sPLA<sub>2</sub> : Qn when subjected to reverse-phase HPLC. (b) shows the MALDI-TOF mass spectrometry analysis of native sPLA<sub>2</sub> and sPLA<sub>2</sub> : Qn, indicating the difference in the molecular mass corresponding to one molecule of bound quercitrin.</table>

BioMed Research International

fig1

Figure 1

Figure 1: An Evaluation of 3-Rhamnosylquercetin, a Glycosylated Form of Quercetin, against the Myotoxic and Edematogenic Effects of sPLA<sub>2</sub> from <i>Crotalus durissus terrificus</i> 

Figure 1 | An Evaluation of 3-Rhamnosylquercetin, a Glycosylated Form of Quercetin, against the Myotoxic and Edematogenic Effects of sPLA2 from Crotalus durissus terrificus 